157 related articles for article (PubMed ID: 33057841)
1. Economic perspective of cancer treatment in India.
Natarajan A; Mehra N; Rajkumar T
Med Oncol; 2020 Oct; 37(11):101. PubMed ID: 33057841
[TBL] [Abstract][Full Text] [Related]
2. The role of generic medicines and biosimilars in oncology in low-income countries.
Renner L; Nkansah FA; Dodoo AN
Ann Oncol; 2013 Sep; 24 Suppl 5():v29-32. PubMed ID: 23975702
[TBL] [Abstract][Full Text] [Related]
3. Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA.
Bennett CL; Sartor OA; Armitage JO; Kantarjian H
Lancet Oncol; 2017 Jan; 18(1):22-23. PubMed ID: 28049571
[No Abstract] [Full Text] [Related]
4. American Society of Clinical Oncology Position Statement on Addressing the Affordability of Cancer Drugs.
American Society of Clinical Oncology
J Oncol Pract; 2018 Mar; 14(3):187-192. PubMed ID: 29091534
[No Abstract] [Full Text] [Related]
5. NCCN Biosimilars White Paper: regulatory, scientific, and patient safety perspectives.
Zelenetz AD; Ahmed I; Braud EL; Cross JD; Davenport-Ennis N; Dickinson BD; Goldberg SE; Gottlieb S; Johnson PE; Lyman GH; Markus R; Matulonis UA; Reinke D; Li EC; DeMartino J; Larsen JK; Hoffman JM
J Natl Compr Canc Netw; 2011 Sep; 9 Suppl 4():S1-22. PubMed ID: 21976013
[TBL] [Abstract][Full Text] [Related]
6. Generics and Biosimilars: Barriers and Opportunities.
Scheckel CJ; Rajkumar SV
Mayo Clin Proc; 2021 Dec; 96(12):2947-2957. PubMed ID: 34728057
[No Abstract] [Full Text] [Related]
7. A Conversation with Gary Lyman, MD: Biosimilars and the Search for the Cure To Cancer Treatment's Financial Toxicity.
Wehrwein P
Manag Care; 2019 Jan; 28(1):12-15. PubMed ID: 30883317
[TBL] [Abstract][Full Text] [Related]
8. Developing oncology biosimilars: an essential approach for the future.
Abraham J
Semin Oncol; 2013 Dec; 40 Suppl 1():S5-24. PubMed ID: 24267944
[TBL] [Abstract][Full Text] [Related]
9. Anti-neoplastic biosimilars--the same rules as for cytotoxic generics cannot be applied.
Mellstedt H
Ann Oncol; 2013 Sep; 24 Suppl 5():v23-8. PubMed ID: 23975701
[TBL] [Abstract][Full Text] [Related]
10. American Heart Association Principles on the Accessibility and Affordability of Drugs and Biologics: A Presidential Advisory From the American Heart Association.
Antman EM; Creager MA; Houser SR; Warner JJ; Konig M;
Circulation; 2017 Dec; 136(24):e441-e447. PubMed ID: 29122813
[TBL] [Abstract][Full Text] [Related]
11. Pharmacoeconomics of cancer therapies: considerations with the introduction of biosimilars.
Henry D; Taylor C
Semin Oncol; 2014 Apr; 41 Suppl 3():S13-20. PubMed ID: 24767632
[TBL] [Abstract][Full Text] [Related]
12. How do biosimilars sustain value, affordability, and access to oncology care?
Simoens S
Expert Rev Pharmacoecon Outcomes Res; 2021 Jun; 21(3):327-329. PubMed ID: 32842809
[No Abstract] [Full Text] [Related]
13. [Can we transfer the mechanisms of the generics market to biosimilars?].
Jacke CO; Wild F
Versicherungsmedizin; 2016 Dec; 68(4):168-72. PubMed ID: 29144113
[TBL] [Abstract][Full Text] [Related]
14. Empower physicians to fight financial toxicity with biosimilars.
Oubre K
Am J Manag Care; 2019 Dec; 25(12 Spec No.):SP374-SP375. PubMed ID: 31860250
[No Abstract] [Full Text] [Related]
15. A GUIDE TO FOLLOW-ON BIOLOGICS AND BIOSIMILARS WITH A FOCUS ON INSULIN.
Dolinar R; Lavernia F; Edelman S
Endocr Pract; 2018 Feb; 24(2):195-204. PubMed ID: 29466056
[TBL] [Abstract][Full Text] [Related]
16. Regulatory and clinical considerations for biosimilar oncology drugs.
Bennett CL; Chen B; Hermanson T; Wyatt MD; Schulz RM; Georgantopoulos P; Kessler S; Raisch DW; Qureshi ZP; Lu ZK; Love BL; Noxon V; Bobolts L; Armitage M; Bian J; Ray P; Ablin RJ; Hrushesky WJ; Macdougall IC; Sartor O; Armitage JO
Lancet Oncol; 2014 Dec; 15(13):e594-e605. PubMed ID: 25456378
[TBL] [Abstract][Full Text] [Related]
17. [The development of biosimilars in oncology].
Jiang SY; Shi YK
Zhonghua Zhong Liu Za Zhi; 2017 Oct; 39(10):721-725. PubMed ID: 29061013
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Access to Novel Drugs for Lymphoma and Chronic Lymphocytic Leukemia Between India and the United States.
Sathyanarayanan V; Flowers CR; Iyer SP
JCO Glob Oncol; 2020 Jul; 6():1124-1133. PubMed ID: 32692628
[TBL] [Abstract][Full Text] [Related]
19. Biosimilars in the Caribbean--key considerations.
Cox SD
West Indian Med J; 2012 Dec; 61(9):849-52. PubMed ID: 24020222
[No Abstract] [Full Text] [Related]
20. Joint 24th Medicines for Europe and 21st International Generic and Biosimilars Association (IGBA) Annual Conference (June 13-15, 2018 - Budapest, Hungary).
Cross G
Drugs Today (Barc); 2018 Aug; 54(8):499-505. PubMed ID: 30209444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]